Antoinette R Tan

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Early Breast Cancer

Epidermal Growth Factor Receptor

Top Venues

JCO precision oncology

Breast cancer (Dove Medical Press)

Future oncology (London, England)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Kaitlyn O'Keefe, Neelam V Desai, Antoinette R Tan
Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Neelam V Desai, Antoinette R Tan
Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline BRCA1 / 2 -Mutated Breast Cancers in the High-Risk, Early-Stage Setting. JCO precision oncology 7 (2023)
Neelam V Desai, Antoinette R Tan
Targeted Therapies and the Evolving Standard of Care for Triple-Negative and Germline BRCA1 / 2 -Mutated Breast Cancers in the High-Risk, Early-Stage Setting. JCO precision oncology 7 (2023)
Antoinette R Tan, Joyce O'Shaughnessy, Subing Cao, Sarah Ahn, John S Yi
Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer. Breast cancer research and treatment (2023)
Sherene Loi, Roberto Salgado, Thomas Powles, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R Tan, Yuan Sun, Vassiliki Karantza, Anran Wang, Lingkang Huang, Assieh Saadatpour, Razvan Cristescu, Jennifer Yearley, Jared Lunceford, Petar Jelinic, Sylvia Adams
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. JCO precision oncology 7 (2023)
Sherene Loi, Roberto Salgado, Thomas Powles, Javier Cortes, David W Cescon, Eric P Winer, Deborah L Toppmeyer, Hope S Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R Tan, Yuan Sun, Vassiliki Karantza, Anran Wang, Lingkang Huang, Assieh Saadatpour, Razvan Cristescu, Jennifer Yearley, Jared Lunceford, Petar Jelinic, Sylvia Adams
Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative Breast Cancer: KEYNOTE-086 Exploratory Analysis. JCO precision oncology 7 (2023)
Shom Goel, Antoinette R Tan, Hope S Rugo, Philippe Aftimos, Zoran Andrić, Andrew P Beelen, Jingshan Zhang, John S Yi, Rajesh K Malik, Joyce O'Shaughnessy
Trilaciclib prior to gemcitabine plus carboplatin for metastatic triple-negative breast cancer: phase III PRESERVE 2. Future oncology (London, England) (2022)
Mark D Pegram, Erika P Hamilton, Antoinette R Tan, Anna Maria Storniolo, Kemal Balic, Anton I Rosenbaum, Meina Liang, Peng He, Shannon Marshall, Anita Scheuber, Mayukh Das, Manish R Patel
First-in-Human, Phase 1 Dose-Escalation Study of Biparatopic Anti-HER2 Antibody-Drug Conjugate MEDI4276 in Patients with HER2-positive Advanced Breast or Gastric Cancer. Molecular cancer therapeutics 20 (8) (2021)
Antoinette R Tan, Nancy Chan, Brian F Kiesel, Mark N Stein, Rebecca A Moss, Jyoti Malhotra, Joseph Aisner, Mansi Shah, Murugesan Gounder, Hongxia Lin, Michael P Kane, Yong Lin, Jiuping Ji, Alice Chen, Jan H Beumer, Janice M Mehnert
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies. Cancer chemotherapy and pharmacology (2021)
Arielle L Heeke, Antoinette R Tan
Checkpoint inhibitor therapy for metastatic triple-negative breast cancer. Cancer metastasis reviews 40 (2) (2021)
Antoinette R Tan, Gail S Wright, Anu R Thummala, Michael A Danso, Lazar Popovic, Timothy J Pluard, Hyo S Han, Željko Vojnović, Nikola Vasev, Ling Ma, Donald A Richards, Sharon T Wilks, Dušan Milenković, Jie Xiao, Jessica Sorrentino, Janet Horton, Joyce O'Shaughnessy
Trilaciclib prior to chemotherapy in patients with metastatic triple-negative breast cancer: final efficacy and subgroup analysis from a randomized phase II study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Megan Jagosky, Antoinette R Tan
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data. Breast cancer (Dove Medical Press) 13 (2021)